BYD/Tesla: China’s carmakers gain ground as profitability is stretched - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
电动汽车

BYD/Tesla: China’s carmakers gain ground as profitability is stretched

Low pricing strategy is not sustainable as raw material prices soar and with electric vehicle subsidies set to be phased out

It is a historic day for China’s answer to Tesla. BYD, the Chinese automaker backed by Warren Buffett’s Berkshire Hathaway, has overtaken Tesla to become the world’s top electric carmaker by sales. China’s carmakers have razor thin margins, but sales are accelerating fast.

BYD sold 641,000 vehicles in the first six months of the year, up more than 300 per cent from the previous year. That compares to 564,000 vehicles sold by Tesla, hit by supply chain and operational disruptions due to China’s lockdowns.

China, once largely seen as a domestically focused electric car market, exported more than half a million electric vehicles last year, more than double the previous year. Government policy has played a part: Beijing requires a fixed quota of electric vehicles to be made each year.

Much of the sales growth is based on low prices. For example, the Hongguang Mini, the best selling electric model in the world last year, was priced at Rmb28,800 ($4,300), before price hikes this year. BYD has a wider range of offerings, including a $34,000 extended-range model. Its pricing is much lower than global counterparts, with a starting price of $15,000 after subsidies for its Dolphin model.

These cheap electric cars make slim profits. SAIC-GM-Wuling, the maker of the Hongguang Mini, posted very thin profit margins last year. BYD operating margins fell below 2 per cent last year. For Tesla during the same period these were 12 per cent.

Ultra low pricing strategies are not sustainable. Global prices of raw materials have soared. Electric cars subsidies are set to be phased out by the end of the year. BYD has lifted the prices of its cars and batteries this year, in line with global peers.

Nonetheless, China increasingly dominates the lithium battery supply chain. That will support the sales growth of its electric carmakers. Shares of BYD have gained a third in the past year, unaffected by the broader sell-off in Chinese equities. They trade at 99 times forward earnings, an 80 per cent premium to Tesla.

The test for BYD will be whether it can attract similar demand overseas. The potential is greatest in south-east Asia and Japan where there is growing demand for small and low cost electric cars. Rapid growth in these price sensitive markets would justify the valuation gap.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

FT社评:伊朗战争让各国央行进退两难

如果各国央行过早通过加息来遏制通胀压力,可能令本已受创的经济雪上加霜;如但果按兵不动、观望冲突的进展,又可能贻误时机。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
3天前
设置字号×
最小
较小
默认
较大
最大
分享×